Primary, iPS and Stem Cells: Emerging Tools for HTS?
Richard Elgen, President, Bio-discovery, PerkinElmer, speaking at Screening Europe 2010
The Stem Cell Space - From a Vendor Perspective
Asaf Shiloni, Business Analyst, PeproTech, speaking at Stem Cells World Congress 2010
High-throughput Screening in Human Embryonic Stem Cells for Drug Discovery
Sabrina C. Desbordes, Senior Postdoctoral Fellow, PRBB-Center for Genomic Regulation (CRG), speaking at Screening Europe 2010
Personalized Stem Cell Therapies for Tissue Regeneration
Sheldon Schaffer, Vice President, Aastrom Biosciences, Speaking at Stem Cells World Congress 2010.
Excitement Over Automated Electrophysiology: Heat Activation of TRPV1 and Action Potentials of Stem Cell Derived Cardiomyocytes
Rodolfo Haedo, Nanion Technologies, General Manager, speaking at Ion Channel Targets 2010.
The Automation of Human Stem Cell Culture
David Williams, Professor, Loughborough University, speaking at Cellular Therapy Summit 2010.
Expanding Primary Cells
Tobias May, Scientist, Helmholtz Centre for Infection Research, speaking at Cellular Therapy Summit 2010.
Engineering Adipose Mesenchymal Stromal Cells for Cancer Therapy
Massimo Dominici, Assistant Professor, University Hospital of Modena and Reggio Emilia, speaking at Cellular Therapy Summit 2010.
Derivation of Endothelial Cells from Stem Cells and Functional Assessment In Vitro and In Vivo
Andrew Baker, Professor, Glasgow University, speaking at Cellular Therapy Summit 2010.